TRIAL STUDYING MAINTENANCE TREATMENT WITH LENALIDOMIDE AND DEXAMETHASONE VERSUS LENALIDOMIDE, DEXAMETHASONE AND MLN9708 AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH NEWLY-DIAGNOSED SYMPTOMATIC MULTIPLE MYELOMA: